Dragon's Blood extract has antithrombotic properties, affecting platelet aggregation functions and anticoagulation activities

J Ethnopharmacol. 2011 May 17;135(2):510-4. doi: 10.1016/j.jep.2011.03.063. Epub 2011 Apr 2.

Abstract

Ethnopharmacological relevance: Dragon's Blood from Dracaena cochinchinensis (Lour.) S.C. Chen (Yunnan, China), as a traditional Chinese medicinal herb, was shown to have certain antithrombotic effects. A new preparation process was used to extract effective components from Dragon's Blood. A 95% ethanol extract A (EA) and a precipitate B (PB) fraction were obtained and compared. Reliability of the preparation process was validated by pharmacodynamic experiments.

Materials and methods: A rat/mouse thrombosis and blood stasis model was developed for this study, and EA and PB effects on thrombosis, platelet functions and blood coagulation activities were analyzed.

Results: It was observed that the EA fraction had significantly better inhibitory effects than the PB fraction on thrombosis (p<0.05), platelet aggregation function (p<0.01) and anticoagulation activity (p<0.05-0.01).

Conclusions: The results obtained here showed that EA fraction from Dragon's Blood contained pharmacologically effective compounds with antithrombotic effects, partially improving platelet function and anticoagulation activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticoagulants / pharmacology*
  • Antithrombins / pharmacology*
  • Mice
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology*
  • Platelet Aggregation Inhibitors / pharmacology*
  • Rats
  • Rats, Wistar

Substances

  • Anticoagulants
  • Antithrombins
  • Plant Extracts
  • Platelet Aggregation Inhibitors
  • dragon's blood